Wild downside of ‘miracle’ weight loss drug

Wild downside of ‘miracle’ weight loss drug

Popular new weight reduction medicine Ozempic and Wegovy have been serving to folks to shed weight, however some customers have additionally reported shedding their hair in addition to an alarming facet impact.

The dear injectable medicine have change into a sensation among the many Hollywood elite, however social media teams for folks taking the treatment embody posts about hair loss, in response to NBC News and the New York Post.

Semaglutide — higher recognized by model names Ozempic and Wegovy — have been initially made for folks affected by Type 2 diabetes, however the medicine have change into more and more prescribed for weight reduction. Tirzepatide, bought beneath the model title Mounjaro for diabetics, has additionally jumped on the scene.

Earlier this yr the so-called “miracle” drug was authorized to be used in Australia, the place is it marketed as Wegovy.

Currently, solely Wegovy is authorized for weight reduction by the US Federal Transit Administration whereas Ozempic and Mounjaro are prescribed off-label by medical doctors.

The medicine have emerged as a preferred various to gastric bypass surgical procedure, which frequently comes with many dangers and issues.

While stories of hair loss as a facet impact of the medicine are unnerving, Dr Vijaya Surampudi, assistant director of the UCLA weight administration program in Los Angeles, informed NBC that it’s not widespread.

“Hair loss is unlikely related to the drugs,” stated Dr Surampudi, who has counselled sufferers who’ve skilled hair loss whereas on the drugs, “but more likely related to weight loss that is a result of these drugs.”

Ozempic doesn’t record hair loss as a facet impact, nonetheless 3 per cent of sufferers reported hair loss throughout Wegovy’s scientific trials, in response to NBC. While they’re the identical drug, Wegovy is a better dose.

In a scientific trial for tirzepatide, 6 per cent of sufferers taking a better dose reported alopecia, whereas 1% of these given a placebo reported hair loss.

Tirzepatide drugmaker Eli Lilly informed NBC in an announcement that the hair loss noticed within the trials was usually short-term, noting that “hair loss is a side effect that has been associated with significant weight loss in many previous clinical trials for obesity treatment.”

Dr Surampudi stated that hair loss is a standard facet impact of main weight reduction, as it may be spurred by stress.

The weight reduction medicine suppress urge for food, “shocking the system,” Dr Surampudi stated.

Those taking the treatment can lose as much as 20 per cent of their physique weight in six to 12 months earlier than weight reduction plateaus, NBC reported.

This article initially appeared on the New York Post and was reproduced with permission

Originally revealed as Weight loss medicine Ozempic and Wegovy are reportedly making folks’s hair fall out

Source: www.dailytelegraph.com.au